Exatecan
Exatecan Basic information
- Product Name:
- Exatecan
- Synonyms:
-
- 10H,13H-BENZO[DE]PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLINE-10,13-DIONE, 1-AMINO-9-ETHYL-5-FLUORO-1,2,3,9,12,15-HEXAHYDRO-9-HYDROXY-4-METHYL-, (1S,9S)-, MONOMETHANESULFONATE (SALT)
- exatecan alideximer
- (1S,9S)-1-Amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-10H,13H-benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-10,13-dione
- Exatecan
- DX 8951
- CS-147
- Exatecan Impurity
- 10H,13H-Benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-10,13-dione, 1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, (1S,9S)-
- CAS:
- 171335-80-1
- MF:
- C24H22FN3O4
- MW:
- 435.45
- Mol File:
- 171335-80-1.mol
Exatecan Chemical Properties
- Boiling point:
- 818.4±65.0 °C(Predicted)
- Density
- 1.53±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C,protect from light
- solubility
- Soluble in DMSO
- pka
- 11.19±0.40(Predicted)
Exatecan Usage And Synthesis
Description
Exatecan is a hexacyclic chemical compound analogous to camptothecin and used as a payload in ADC research. Exatecan mesylate is used as an inhibitor of DNA topoisomerase I, which plays a key role in DNA replication, transcription, and recombination.
Definition
ChEBI: Exatecan is a pyranoindolizinoquinoline.
Biological Activity
Exatecan (DX-8951) is a DNA topoisomerase I (topoisomerase I) inhibitor with IC50 of 2.2 μM (0.975 μg/mL) for cancer research.
in vitro
Exatecan is a potent topoisomerase I inhibitor, with an IC 50 of 0.975 μg/mL. Exatecan Mesylate (DX-8951f) significantly inhibits the proliferation of several cancer cell lines, with mean GI 50 s of 2.02 ng/mL, 2.92 ng/mL, 1.53 ng/mL, and 0.877 ng/mL for breast cancer cells, colon cancer cells, stomach cancer cells and lung cancer cells, respectively. Exatecan Mesylate (DX-8951f) displays cytotoxic activities against PC-6, PC-6/SN2-5 cells, with mean GI 50 s of 0.186 and 0.395 ng/mL, respctively. Exatecan Mesylate (34 nM) stabilizes DNA-TopoI complexes in PC-6 and PC-6/SN2-5 cells.
in vivo
Exatecan Mesylate (DX-8951f, 3.325-50 mg/kg, i.v.) exhibits antitumor activities in the mice model bearing tumor cells, without toxic death. Exatecan Mesylate (15, 25 mg/kg, i.v.) hightly inhibits MIA-PaCa, BxPC-3 primary tumor growth in the MIA-PaCa-2 early-stage model and early-stage model of BxPC-3. Exatecan Mesylate (15, 25 mg/kg, i.v.) also significantly suppresses BxPC-3 lymphatic metastasis and completely eliminates lung metastasis in the BxPC-3 late-stage cancer model.
ExatecanSupplier
- Tel
- 027-027-83984790 17720532645
- t17720532645@163.com
- Tel
- 021-50896099 18017206244
- sales@tekanbio.com
- Tel
- 021-61001086 13671938079
- sales@wuyanpharm.com
- Tel
- 13184580281
- hj@ruiweier.cn
- Tel
- 18117455885
- qihongchem@163.com
Exatecan(171335-80-1)Related Product Information
- CHLOROPHOSPHONAZO III
- Thiophanate-methyl
- Piroxicam
- Methyl salicylate
- Bensulfuron methyl
- Kresoxim-methyl
- Methyl
- 7,11-Diethyl-10-hydroxycaMptothecin
- Irinotecan Impurity 24
- RPR121056A
- 4-Piperidinopiperidine
- 10-O-Acetyl SN-38
- (+)-Camptothecin
- 12-Hydroxy Irinotecan
- 10-Hydroxycamptothecin
- 7-Ethylcamptothecin
- 7-Ethyl-10-(4-amino-1-piperidino)carbonyloxycamptothecin
- 7-Ethyl-10-hydroxycamptothecin